FI974601A0 - Veren triglyseriditason kohoamista estävä peptidi ja mainittua peptidiä aktiivisena aineosana sisältävä veren triglyseriditason kohoamisen estäjä - Google Patents

Veren triglyseriditason kohoamista estävä peptidi ja mainittua peptidiä aktiivisena aineosana sisältävä veren triglyseriditason kohoamisen estäjä

Info

Publication number
FI974601A0
FI974601A0 FI974601A FI974601A FI974601A0 FI 974601 A0 FI974601 A0 FI 974601A0 FI 974601 A FI974601 A FI 974601A FI 974601 A FI974601 A FI 974601A FI 974601 A0 FI974601 A0 FI 974601A0
Authority
FI
Finland
Prior art keywords
peptide
blood
level
active component
triglyceride
Prior art date
Application number
FI974601A
Other languages
English (en)
Swedish (sv)
Other versions
FI116660B (fi
FI974601A (fi
Inventor
Kyoichi Kagawa
Chizuko Fukuhama
Hisako Matsutaka
Toyoo Nakamura
Masahiro Numata
Shigeaki Watanabe
Kazuhisa Honda
Original Assignee
Hankyu Kyoei Bussan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14126034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI974601(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hankyu Kyoei Bussan Co Ltd filed Critical Hankyu Kyoei Bussan Co Ltd
Publication of FI974601A0 publication Critical patent/FI974601A0/fi
Publication of FI974601A publication Critical patent/FI974601A/fi
Application granted granted Critical
Publication of FI116660B publication Critical patent/FI116660B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FI974601A 1995-06-23 1997-12-22 Veren triglyseriditason kohoamista estävä peptidi ja mainittua peptidiä aktiivisena aineosana sisältävä veren triglyseriditason kohoamisen estäjä FI116660B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP1995/001264 WO1997000890A1 (en) 1995-06-23 1995-06-23 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient
JP9501264 1995-06-23

Publications (3)

Publication Number Publication Date
FI974601A0 true FI974601A0 (fi) 1997-12-22
FI974601A FI974601A (fi) 1997-12-22
FI116660B FI116660B (fi) 2006-01-31

Family

ID=14126034

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974601A FI116660B (fi) 1995-06-23 1997-12-22 Veren triglyseriditason kohoamista estävä peptidi ja mainittua peptidiä aktiivisena aineosana sisältävä veren triglyseriditason kohoamisen estäjä

Country Status (8)

Country Link
EP (1) EP0838474B1 (fi)
KR (1) KR100262468B1 (fi)
AT (1) ATE292142T1 (fi)
AU (1) AU708938B2 (fi)
DK (1) DK0838474T3 (fi)
ES (1) ES2238682T3 (fi)
FI (1) FI116660B (fi)
WO (1) WO1997000890A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
GB0211849D0 (en) * 2002-05-23 2002-07-03 Mok Kenneth H Improvments to retro-inverso isomers
JP4395658B2 (ja) * 2005-11-17 2010-01-13 エムジーファーマ株式会社 コレステロール再上昇抑制用組成物およびその用法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335567C (en) * 1988-02-02 1995-05-16 Kyoichi Kagawa Lipid metabolism promoting agent
JPH0331298A (ja) * 1989-06-28 1991-02-12 Ajinomoto Co Inc プロリルエンドペプチターゼ阻害ペプチド
JPH03167199A (ja) * 1989-11-24 1991-07-19 Yamanouchi Pharmaceut Co Ltd 新規ヘプタペプチド
JP3312944B2 (ja) * 1993-03-24 2002-08-12 伊藤ハム株式会社 脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤
JP2800877B2 (ja) * 1993-12-28 1998-09-21 伊藤ハム株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤

Also Published As

Publication number Publication date
ATE292142T1 (de) 2005-04-15
AU708938B2 (en) 1999-08-19
KR19990028359A (ko) 1999-04-15
EP0838474A4 (en) 2001-04-18
EP0838474B1 (en) 2005-03-30
AU2753295A (en) 1997-01-22
DK0838474T3 (da) 2005-08-01
FI116660B (fi) 2006-01-31
KR100262468B1 (ko) 2000-08-01
ES2238682T3 (es) 2005-09-01
WO1997000890A1 (en) 1997-01-09
EP0838474A1 (en) 1998-04-29
FI974601A (fi) 1997-12-22

Similar Documents

Publication Publication Date Title
AU690853B2 (en) Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
ES2153415T3 (es) Peptido inhibidor de la diferenciacion de adipocitos e inhibidor de la diferenciacion de adipocitos que contiene dicho peptido como ingrediente activo.
GT200000057A (es) Compuestos para tratar la obesidad.
EA200200847A1 (ru) Производные пиперазина и пиперидина для лечения и профилактики поврежденных нейронов
DE60333868D1 (de) Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
FI974601A0 (fi) Veren triglyseriditason kohoamista estävä peptidi ja mainittua peptidiä aktiivisena aineosana sisältävä veren triglyseriditason kohoamisen estäjä
Croom et al. Neuropeptide Y, peptide YY and aluminum in Alzheimer’s disease:: Is there an etiological relationship?
CO4520179A1 (es) Composiciones de accion sinergistica, protectoras de plantas, que tienen al menos un componente de accion inmunizante y el otro componente es seleccionado de dimetoformo, triciclazol o probenazol, asi como un vehiculo adecuado
DE69739737D1 (de) Methode zur Behandlung von Muskelkrankheiten
DK200001822A (da) Kontrol af parasitinfestationer hos opdrættede og vilde fisk
CA2225412A1 (en) A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
CA2060491A1 (en) Compositions and method for modulating eicosanoid mediated immune responses in invertebrates
ATE152879T1 (de) Antiparasitäre zusammensetzung zur verwendung bei tieren
ATE231001T1 (de) Verwendung von protein c inhibitor zur behandlung disseminierter intravasaler gerinnung (dic)
ATE350034T1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus
WO2003096964A3 (en) Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
RU93016219A (ru) Способ кормления сельскохозяйственной птицы
RU2007131732A (ru) Способ разрушения бактерий или подавления роста бактерий в субстрате
NO976042L (no) Peptid som inhiberer ökning av triglyceridnivå i blod, og inhibitor av ökning av triglyceridnivå i blod inneholdende nevnte peptid som aktiv bestanddel

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116660

Country of ref document: FI